Literature DB >> 9691019

An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.

N Tomita1, M Horiuchi, S Tomita, G H Gibbons, J Y Kim, D Baran, V J Dzau.   

Abstract

The transcription factor E2F controls expression of several genes involved in cell proliferation including c-myc, c-myb, proliferating cell nuclear antigen (PCNA), and cdk2 kinase. Having established that both PCNA and cdk2 kinase are induced in rat mesangial cells (MC) by serum stimulation, we attempted to inhibit MC proliferation in vitro by transfecting these cells with cationic liposomes containing a synthetic double-stranded oligodeoxynucleotide (ODN) with high affinity for E2F. Using a gel mobility shift assay, we detected increased specific binding of E2F in MC following serum stimulation. This binding was completely inhibited by preincubation of MC nuclear extracts with the double-stranded ODN with high affinity for E2F but not by preincubation with a missense ODN containing two point mutations. MC were also transfected with a luciferase reporter gene construct containing three E2F binding sites. Luciferase activity was enhanced by serum stimulation of MC, and this effect was specifically abolished by cotransfection of MC with E2F decoy ODN. Furthermore, RT-PCR analysis revealed that serum-induced upregulation of PCNA and cdk2 kinase gene expression was inhibited by E2F decoy ODN transfection but not by transfection of missense ODN. These changes in gene expression were paralleled by a reduction in PCNA and cdk2 kinase protein expression in E2F decoy ODN transfected cells. MC number increased following serum stimulation. This effect was blunted by transfection with E2F decoy ODN but not by transfection of missense ODN. These data suggest that the transcription factor E2F plays a crucial role in the regulation of MC proliferation and that this factor can be successfully targeted to inhibit MC cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691019     DOI: 10.1152/ajprenal.1998.275.2.F278

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

2.  Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

Authors:  Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2011-07-29       Impact factor: 15.419

3.  Cold Shock Proteins Mediate GN with Mesangioproliferation.

Authors:  Cheng Zhu; Eva Sauter; Anja Schreiter; Claudia R C van Roeyen; Tammo Ostendorf; Jürgen Floege; Florian Gembardt; Christian P Hugo; Berend Isermann; Jonathan A Lindquist; Peter R Mertens
Journal:  J Am Soc Nephrol       Date:  2016-05-05       Impact factor: 10.121

Review 4.  Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.

Authors:  Naruya Tomita; Naoki Kashihara; Ryuichi Morishita
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

5.  MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro.

Authors:  Cristen B Chafin; Nicole L Regna; David L Caudell; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2013-11-18       Impact factor: 11.530

6.  Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence.

Authors:  Xiaoxin S Xu; Xin Hong; Gan Wang
Journal:  J Hematol Oncol       Date:  2009-03-27       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.